Can we predict favourable quality of life after surgically treated vertebral osteomyelitis? Analysis of a prospective study.

Oswestry Disability Index (ODI) Patient-related outcome measures (PROMs) Predicting factors Quality of life (QoL) Spondylodiscitis

Journal

Archives of orthopaedic and trauma surgery
ISSN: 1434-3916
Titre abrégé: Arch Orthop Trauma Surg
Pays: Germany
ID NLM: 9011043

Informations de publication

Date de publication:
May 2023
Historique:
received: 14 11 2021
accepted: 12 03 2022
medline: 19 4 2023
pubmed: 2 4 2022
entrez: 1 4 2022
Statut: ppublish

Résumé

Vertebral osteomyelitis (VO) is a severe clinical entity associated with significant morbidity and mortality. Several studies have showed that successful treatment of VO patients leads to significantly improved quality of life (QoL). Nevertheless, QoL levels of these patients remained below those of the general population. There are rarely studies focusing on predicting factors for favourable QoL after surgically treated VO. The aim of this study was to identify factors influencing positively the QoL of patients undergoing surgery for VO. We conducted a prospective monocentric study including surgically treated VO patients from 2008 to 2016. Data were collected before (T0) and 1 year (T1) after surgery. Primary outcome was favourable QoL defined as back pain with disability restricting normal life activity with a cutoff value ≥ 12 on Oswestry Disability Index (ODI). Ethical approval was given by the Faculty of Medicine at the University of Cologne (09-182). A total of 119 patients surviving 1 year after surgically treated VO were analysed. Favourable QoL was achieved in 35/119 patients. On multivariate analysis, younger age (hazard ratio = HR: 0.95; 95% CI 0.91-0.99; p = 0.022), lower albumin (HR: 0.9; 0.83-0.98; p = 0.019) an ASA score ≤ 2 (HR:4.24; 95%CI 1.42-12.68; p = 0.010), and a lower preoperative leg pain on the VAS (HR: 0.86; 95% CI 0.76-0.97; p = 0.018) were identified as independent risk factors for favourable QoL. Interestingly, the absence of neurological deficits was not predictive for a favourable outcome by means of QoL. One-third of surgically treated VO patients (29%) in our cohort achieved favourable QoL by means of ODI. Our findings can facilitate an estimation of the prognosis when informing the patient before surgery, and underscore that spine disability questionnaires, such as ODI, measuring QoL, are mandatory to evaluate comprehensively the outcome of this entity.

Identifiants

pubmed: 35359162
doi: 10.1007/s00402-022-04431-3
pii: 10.1007/s00402-022-04431-3
pmc: PMC10110645
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2317-2324

Informations de copyright

© 2022. The Author(s).

Références

Spine (Phila Pa 1976). 2020 Oct 15;45(20):1426-1434
pubmed: 32453235
Eur Spine J. 2016 Apr;25(4):983-99
pubmed: 26585975
Eur Spine J. 2018 Jun;27(Suppl 2):229-236
pubmed: 29667140
Clin Microbiol Infect. 2012 Dec;18 Suppl 7:1-8
pubmed: 23137133
Spine J. 2015 Jun 1;15(6):1233-40
pubmed: 25701609
J Infect. 2021 Sep;83(3):314-320
pubmed: 34146597
Dtsch Arztebl Int. 2017 Dec 25;114(51-52):875-882
pubmed: 29321098
Spine (Phila Pa 1976). 2000 Nov 15;25(22):2940-52; discussion 2952
pubmed: 11074683
Spine J. 2019 May;19(5):880-887
pubmed: 30500465
J Infect. 2008 Aug;57(2):128-31
pubmed: 18562009
Pneumologie. 2017 Jun;71(6):325-397
pubmed: 28651293
BMC Musculoskelet Disord. 2013 Apr 26;14:148
pubmed: 23622053
Diagn Microbiol Infect Dis. 2019 May;94(1):66-72
pubmed: 30594411
Spine (Phila Pa 1976). 2008 Apr 15;33(8):E246-53
pubmed: 18404094
Semin Arthritis Rheum. 2009 Aug;39(1):10-7
pubmed: 18550153
Br Med Bull. 2016 Mar;117(1):121-38
pubmed: 26872859
J Infect. 2014 Sep;69(3):252-8
pubmed: 24844824
Dtsch Arztebl Int. 2008 Mar;105(10):181-7
pubmed: 19629222
Eur Spine J. 2021 Jun;30(6):1721-1731
pubmed: 32613398
J Orthop Surg (Hong Kong). 2017 May-Aug;25(2):2309499017716068
pubmed: 28639530
Medicine (Baltimore). 2017 May;96(21):e6387
pubmed: 28538361
Infect Dis (Lond). 2016;48(3):201-8
pubmed: 26484577
Eur Spine J. 2012 Aug;21(8):1596-602
pubmed: 22298236
Open Forum Infect Dis. 2014 Dec 05;1(3):ofu107
pubmed: 25734175
Arch Orthop Trauma Surg. 2010 Sep;130(9):1083-91
pubmed: 19771436

Auteurs

A Yagdiran (A)

Department of Orthopedic and Trauma Surgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany. ayla.yagdiran@uk-koeln.de.

C Otto-Lambertz (C)

Department of Orthopedic and Trauma Surgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

B Sondermann (B)

Department of Orthopedic and Trauma Surgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

A Ernst (A)

Faculty of Medicine and University Hospital Cologne Institute of Medical Statistics and Computational Biology, University of Cologne, Cologne, Germany.

D Jochimsen (D)

Division of Infectious Diseases, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

R Sobottke (R)

Department for Spine Surgery, Neurosurgery and Orthopedics, Rhein-Maas Klinikum GmbH, Mauerfeldchen 25, 52146, Würselen, Germany.

J Siewe (J)

Department for Spine Surgery, Klinikum Leverkusen gGmbH, Am Gesundheitspark 11, 51375, Leverkusen, Germany.

P Eysel (P)

Department of Orthopedic and Trauma Surgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

N Jung (N)

Division of Infectious Diseases, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH